Search

everythinglearnresearchcommunity

for

Search:↓

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Careful planning and accurate diagnosis are crucial for successful hair restoration surgery.

Dermal Wnt/β-catenin signaling is important for the proper size and development of hair follicles.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Microemulsions and nanoemulsions can effectively deliver drugs through the skin, but more research is needed to understand their differences and mechanisms.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Injections are effective and safe for rejuvenating neck, chest, and hands.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

New treatments for skin damage from UV light using stem cells and their secretions show promise for skin repair without major risks.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Two adults with unusual scalp fungus symptoms were successfully treated.

A dermoscope helps accurately tell apart Pityrosporum folliculitis and Acne vulgaris.